Infectious abscess affecting the bursal sacs at two or more anatomically distinct sites simultaneously, classified under other bursopathies in the musculoskeletal chapter.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M71.09.
Source · Editorial brief grounded in 4 cited references ↓
- Name each affected bursa explicitly (e.g., 'prepatellar bursa right knee and olecranon bursa left elbow') — vague multi-site language alone won't defend M71.09 on audit.
- Document the infectious nature of the abscess: purulent aspirate, positive culture, or clinical findings consistent with suppurative bursitis distinguish M71.09 from non-infectious bursopathy codes.
- Record any imaging findings (ultrasound, MRI) that confirm fluid collection with abscess characteristics at each named site.
- If the causative organism is identified, add a pathogen code (B95–B98) as a secondary diagnosis per ICD-10-CM 'use additional code' instructions.
- Capture MCC-qualifying comorbidities in the encounter note — they determine DRG 557 vs. 558 and directly affect facility payment.
Related CPT procedures
Procedure codes commonly billed with M71.09. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M71.09 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M71.09 when only one bursa is infected — if a single site is documented, use the site-specific lateralized M71.0x code instead.
- Confusing M71.0x (infectious abscess of bursa) with M70.x (use/overuse bursitis) — if the note says 'bursitis from repetitive motion' without abscess documentation, M71.09 is wrong.
- Assigning M71.09 when the abscess is in surrounding soft tissue rather than within the bursa itself — cutaneous abscess defaults to L02.x, not M71.
- Omitting the secondary organism code when culture results are available, leaving a compliance gap and reducing clinical specificity on the claim.
- Using M71.09 for bilateral involvement of the same bursa type (e.g., both olecranon bursae) when bilateral site-specific codes exist — verify whether a bilateral or multi-site code is more precise for the documented anatomy.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M71.09 applies when a provider documents purulent infection (abscess) within the bursa at multiple separate anatomical sites — for example, concurrent prepatellar and olecranon bursal abscesses. This is the only code in the M71.0x subcategory that captures multi-site involvement; every other M71.0x code is site-specific and lateral (e.g., M71.061 right knee, M71.072 left ankle and foot). Use M71.09 only when the record clearly documents more than one distinct bursa is infected, not simply one bursa with surrounding soft-tissue extension.
M71.0x codes belong to the M71 category, which covers bursopathies not attributable to overuse or repetitive mechanical stress. When bursitis is infectious in origin, M71 is correct — not M70, which is reserved for use/pressure-related bursitis. If the causative organism is known, add a secondary code from B95–B98 to identify the pathogen per ICD-10-CM guidelines.
MS-DRG v43.0 groups M71.09 into DRG 557 (Tendonitis, myositis and bursitis with MCC) or DRG 558 (without MCC), so accurate MCC documentation directly affects reimbursement. If only one bursa is involved, drop to the site-specific M71.0x code for that location rather than defaulting to M71.09.
Sibling codes
Other billable codes under M71.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01When does a multi-bursa infection qualify for M71.09 vs. separate site-specific M71.0x codes?
02Does M71.09 require laterality documentation?
03What is the difference between M71.09 and M71.08?
04Should I code the organism separately when using M71.09?
05Can M71.09 be used for septic bursitis caused by gout or crystal deposits?
06Which DRGs does M71.09 map to?
07Is M71.09 valid for outpatient and inpatient encounters?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 — https://icd10cmtool.cdc.gov/
- 02icd10data.com 2026 ICD-10-CM M71.09 — https://www.icd10data.com/ICD10CM/Codes/M00-M99/M70-M79/M71-/M71.09
- 03AAPC Codify M71.09 — https://www.aapc.com/codes/icd-10-codes/M71.09
- 04CMS MS-DRG v43.0 Grouper Documentation
Mira AI Scribe
Mira AI Scribe captures the names and locations of each infected bursa, presence of purulent fluid or abscess on aspiration or imaging, culture and sensitivity results, and any systemic signs of infection. This detail locks in M71.09 over a non-specific bursopathy code, supports the secondary pathogen code, and provides the MCC documentation that separates DRG 557 from DRG 558.
See how Mira captures M71.09 documentation